Literature DB >> 25841594

Breast cancer screening: an evidence-based update.

Mackenzie S Fuller1, Christoph I Lee2, Joann G Elmore3.   

Abstract

Routine screening mammography is recommended by most groups issuing breast cancer screening guidelines, especially for women 50 years of age and older. However, both the potential benefits and risks of screening should be discussed with individual patients to allow for shared decision making regarding their participation in screening, age of commencement and conclusion, and interval of mammography screening.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Breast cancer screening; Breast self-examination; Clinical breast examination; Informed decision making; MRI; Mammography; Overdiagnosis

Mesh：

Year:  2015        PMID： 25841594      PMCID： PMC5064844          DOI： 10.1016/j.mcna.2015.01.002

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN： 0025-7125            Impact factor:   5.456


  96 in total

1.  Cost-effectiveness of breast MR imaging and screen-film mammography for screening BRCA1 gene mutation carriers.

Authors:  Janie M Lee; Pamela M McMahon; Chung Y Kong; Daniel B Kopans; Paula D Ryan; Elissa M Ozanne; Elkan F Halpern; G Scott Gazelle
Journal:  Radiology       Date:  2010-03       Impact factor: 11.105

2.  Cumulative probability of false-positive recall or biopsy recommendation after 10 years of screening mammography: a cohort study.

Authors:  Rebecca A Hubbard; Karla Kerlikowske; Chris I Flowers; Bonnie C Yankaskas; Weiwei Zhu; Diana L Miglioretti
Journal:  Ann Intern Med       Date:  2011-10-18       Impact factor: 25.391

3.  Follow-up and final results of the Oslo I Study comparing screen-film mammography and full-field digital mammography with soft-copy reading.

Authors:  P Skaane; A Skjennald; K Young; E Egge; I Jebsen; E M Sager; B Scheel; E Søvik; A K Ertzaas; S Hofvind; M Abdelnoor
Journal:  Acta Radiol       Date:  2005-11       Impact factor: 1.990

4.  Screening mammography and risk of breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study.

Authors:  Steven A Narod; Jan Lubinski; Parviz Ghadirian; Henry T Lynch; Pal Moller; William D Foulkes; Barry Rosen; Charmaine Kim-Sing; Claudine Isaacs; Susan Domchek; Susan Domcheck; Ping Sun
Journal:  Lancet Oncol       Date:  2006-05       Impact factor: 41.316

5.  Quantifying the benefits and harms of screening mammography.

Authors:  H Gilbert Welch; Honor J Passow
Journal:  JAMA Intern Med       Date:  2014-03       Impact factor: 21.873

6.  Short-term outcomes of screening mammography using computer-aided detection: a population-based study of medicare enrollees.

Authors:  Joshua J Fenton; Guibo Xing; Joann G Elmore; Heejung Bang; Steven L Chen; Karen K Lindfors; Laura-Mae Baldwin
Journal:  Ann Intern Med       Date:  2013-04-16       Impact factor: 25.391

7.  Calculated risk of breast cancer following mantle irradiation determined by measured dose.

Authors:  N A Janjan; D L Zellmer
Journal:  Cancer Detect Prev       Date:  1992

8.  A BRCA1/2 mutation, high breast density and prominent pushing margins of a tumor independently contribute to a frequent false-negative mammography.

Authors:  Madeleine Tilanus-Linthorst; Leon Verhoog; Inge-Marie Obdeijn; Karina Bartels; Marian Menke-Pluymers; Alexander Eggermont; Jan Klijn; Hanne Meijers-Heijboer; Theo van der Kwast; Cecile Brekelmans
Journal:  Int J Cancer       Date:  2002-11-01       Impact factor: 7.396

Review 9.  A systematic assessment of benefits and risks to guide breast cancer screening decisions.

Authors:  Lydia E Pace; Nancy L Keating
Journal:  JAMA       Date:  2014-04-02       Impact factor: 56.272

10.  Complexities in the estimation of overdiagnosis in breast cancer screening.

Authors:  S W Duffy; E Lynge; H Jonsson; S Ayyaz; A H Olsen
Journal:  Br J Cancer       Date:  2008-09-02       Impact factor: 7.640
View more
  17 in total

Review 1.  [Diagnostic imaging of breast cancer : An update].

Authors:  M Funke
Journal:  Radiologe       Date:  2016-10       Impact factor: 0.635

Review 2.  Application of Disease Etiology and Natural History to Prevention in Primary Health Care: A Discourse.

Authors:  Franklin White
Journal:  Med Princ Pract       Date:  2020-05-18       Impact factor: 1.927

3.  Risk-reducing medications for primary breast cancer: a network meta-analysis.

Authors:  Simone Mocellin; Annabel Goodwin; Sandro Pasquali
Journal:  Cochrane Database Syst Rev       Date:  2019-04-29

4.  Mouse Mammary Gland Whole Mount Density Assessment across Different Morphologies Using a Bifurcated Program for Image Processing.

Authors:  Brendan L Rooney; Brian P Rooney; Vinona Muralidaran; Weisheng Wang; Priscilla A Furth
Journal:  Am J Pathol       Date:  2022-09-14       Impact factor: 5.770

5.  Factors associated with upper limb dysfunction in breast cancer survivors.

Authors:  Thais Cristina Siqueira; Simone Pedrozo Frágoas; Andreia Pelegrini; Ana Rosa de Oliveira; Clarissa Medeiros da Luz
Journal:  Support Care Cancer       Date:  2020-08-17       Impact factor: 3.603

6.  Influence of Discomfort Tolerance of Women who Undergo Mammography on the Perceived Pain Intensity Due to the Procedure.

Authors:  Neriman Akansel; Muaz Gülşen; Muhammed Gültaş
Journal:  Eur J Breast Health       Date:  2020-12-24

7.  Comparison of segmentation-free and segmentation-dependent computer-aided diagnosis of breast masses on a public mammography dataset.

Authors:  Rebecca Sawyer Lee; Jared A Dunnmon; Ann He; Siyi Tang; Christopher Ré; Daniel L Rubin
Journal:  J Biomed Inform       Date:  2020-12-11       Impact factor: 6.317

8.  Impact of the radiographic examination on diagnosis and treatment decision of caries lesions in primary teeth--the Caries Detection in Children (CARDEC-01) trial: study protocol for a randomized controlled trial.

Authors:  Fausto Medeiros Mendes; Laura Regina Antunes Pontes; Thais Gimenez; Juan Sebastian Lara; Lucila Basto de Camargo; Edgard Michel-Crosato; Claudio Mendes Pannuti; Daniela Prócida Raggio; Mariana Minatel Braga; Tatiane Fernandes Novaes
Journal:  Trials       Date:  2016-02-09       Impact factor: 2.279

9.  Changing the Paradigm of Cancer Screening, Prevention, and Treatment.

Authors:  Mohan Doss
Journal:  Dose Response       Date:  2016-11-30       Impact factor: 2.658

Review 10.  Combination Therapy, a Promising Approach to Enhance the Efficacy of Radionuclide and Targeted Radionuclide Therapy of Prostate and Breast Cancer.

Authors:  Tyrillshall S T Damiana; Simone U Dalm
Journal:  Pharmaceutics       Date:  2021-05-07       Impact factor: 6.321
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.